Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
about
Psychosocial interventions for self-harm in adultsPharmacological interventions for self-harm in adultsInterventions for self-harm in children and adolescentsAnticholinergics for urinary symptoms in multiple sclerosisOral protein calorie supplementation for children with chronic diseaseDeferasirox for managing iron overload in people with myelodysplastic syndromeDeferasirox for managing transfusional iron overload in people with sickle cell diseaseAppetite stimulants for people with cystic fibrosisDrug therapies for reducing gastric acidity in people with cystic fibrosisManagement of sexual dysfunction due to antipsychotic drug therapyNon-invasive ventilation for cystic fibrosisDrug therapies for reducing gastric acidity in people with cystic fibrosisOxygen therapy for cystic fibrosisNebulized and oral thiol derivatives for pulmonary disease in cystic fibrosisInspiratory muscle training for cystic fibrosisMacrolide antibiotics for cystic fibrosisDeferasirox for managing iron overload in people with thalassaemiaMacrolide antibiotics for cystic fibrosisCalcium channel blockers for neuroleptic-induced tardive dyskinesiaStretch for the treatment and prevention of contracturesDrugs and pacemakers for vasovagal, carotid sinus and situational syncopeDeferasirox for managing transfusional iron overload in people with sickle cell diseaseDeferasirox for managing iron overload in people with myelodysplastic syndromeInspiratory muscle training for cystic fibrosisNebulized and oral thiol derivatives for pulmonary disease in cystic fibrosisOxygen therapy for cystic fibrosisNon-invasive ventilation for cystic fibrosisAnticholinergics for urinary symptoms in multiple sclerosisAppetite stimulants for people with cystic fibrosisDeferasirox for managing iron overload in people with thalassaemiaPharmacological interventions for clozapine-induced hypersalivationDeferasirox for managing iron overload in patients with myelodysplastic syndromeDeferasirox for managing transfusional iron overload in people with sickle cell diseaseNon-invasive ventilation for cystic fibrosisPotassium supplementation for the management of primary hypertension in adultsMagnesium supplementation for the management of primary hypertension in adultsShort-term ambulatory oxygen for chronic obstructive pulmonary diseaseOxygen therapy for cystic fibrosisCalcium supplementation for the management of primary hypertension in adultsShort acting insulin analogues versus regular human insulin in patients with diabetes mellitus
P2860
Q24185772-820FA6D6-37D0-461B-B13E-07155ACDCED0Q24186543-87BC5011-0FBC-40F5-BD0A-F89A06D9D5A3Q24187033-841285DB-9FD0-409D-8478-3FB4FE535AFEQ24187386-A393D560-6847-4C17-B201-730A38C92EA7Q24187820-93A6598E-217F-4945-9063-53BC7F97FDB1Q24193067-FC649DFC-71D9-4DF5-B6FD-6DFAC8EE07C5Q24194549-6864F74F-2681-402E-9B83-CBE4AB614D5EQ24194798-B8B15FEB-4C94-4356-B67B-DEAB7D35F46AQ24194860-FD992AAD-F2B7-4143-96E9-A662C4664FE1Q24197558-71202DDA-A4F3-400B-9063-99047D767E8EQ24197658-5985E80D-0AB8-4F4E-8DB2-02BBCFDF4793Q24200289-7D4952BB-5F09-49DA-8FAE-17B6A2BA7C69Q24201043-54F8ABDF-E68D-497B-B84E-ABDB439C7572Q24201222-5DD396D6-01BC-4095-BF81-824877BB9586Q24202380-174EB3BD-9E3C-45E0-B9A6-CA773E2C4E85Q24202885-BA22FF63-4357-4FCD-A167-0671A9BC0683Q24203718-FD457018-9D8E-4DA0-A772-9A4E122FC529Q24234430-6E6D6E2D-8E51-4C0A-8AB8-B75B2C10245BQ24235247-14FD5D67-66AE-42D5-9760-F5F2ACAE8956Q24235508-EB58211B-CDD9-4BB6-8628-B1ABC09A6564Q24235975-3CB44BE3-403B-4D69-944E-9E12B756177FQ24236463-E103C511-51DE-4145-9B38-07BCF3FDCD66Q24236532-46486FDA-83BB-401D-92B0-2D1E5CFC0F2EQ24241004-2BD54D3E-81A3-4052-95C5-9628812C91F0Q24241156-415239E6-5E83-4FDF-8936-4C88267C3951Q24241181-10B2C991-2CCE-4854-A39A-95748DC4CD4FQ24241448-2C13BDE1-7856-47CF-A064-579DE7652A66Q24241666-271B8B03-2FD4-49F4-994C-6395815BE676Q24241685-6C0B15E9-5B26-435F-80BC-7B355DD82DFEQ24241753-C5335717-1AA9-4245-93E0-494F08518483Q24242126-8B93BCAB-36E5-4344-8703-6D86398FE421Q24242437-777EDFF2-8C1F-4F2E-B048-07A0E9B55FE2Q24242535-E52FCE4D-B673-4E83-B091-B1CABB62935AQ24243587-4CEE94B1-5C15-4CAE-A9AA-5DF8BD4CD181Q24245403-0BA539CD-E136-41C2-96F9-260833818A76Q24245572-57477D84-6056-4AA8-8BE5-D951C8B09574Q24245685-9E785A2F-1D31-4DDF-AD48-A65539506C3BQ24245714-C77589D9-D3F4-4E38-8127-956A91DA826BQ24246127-B39CEC37-755E-4754-861E-60F18151A1A8Q24246142-6CB60EBE-55A0-4BCD-A569-2E3729B7651A
P2860
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
@en
type
label
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
@en
prefLabel
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
@en
P2860
P356
P1476
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
@en
P2093
François Curtin
P2860
P304
P356
10.1002/SIM.1205
P407
P577
2002-08-01T00:00:00Z